PPP1R2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.791200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.446200E-01
Normal-vs-Stage2
4.692800E-01
Normal-vs-Stage3
1.141810E-01
Normal-vs-Stage4
6.933000E-01
Stage1-vs-Stage2
8.153000E-01
Stage1-vs-Stage3
3.055600E-01
Stage1-vs-Stage4
1.734770E-01
Stage2-vs-Stage3
2.021800E-01
Stage2-vs-Stage4
1.959550E-01
Stage3-vs-Stage4
6.210000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.548200E-01
Normal-vs-AfricanAmerican
9.544800E-01
Normal-vs-Asian
2.411000E-01
Caucasian-vs-AfricanAmerican
4.963000E-01
Caucasian-vs-Asian
3.901600E-01
AfricanAmerican-vs-Asian
2.332600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.405800E-01
Normal-vs-Female
5.505400E-01
Male-vs-Female
4.546600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.473000E-01
Normal-vs-Age(41-60Yrs)
8.336400E-01
Normal-vs-Age(61-80Yrs)
3.940000E-01
Normal-vs-Age(81-100Yrs)
9.835600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.163400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.193200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.829800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.492360E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.472500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.030000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.495800E-01
Normal-vs-Daily Drinker
5.825900E-02
Normal-vs-Weekly Drinker
2.813600E-01
Normal-vs-Occasional Drinker
9.525400E-01
Normal-vs-Social Drinker
3.471000E-01
Non Drinker-vs-Daily Drinker
2.143600E-01
Non Drinker-vs-Weekly Drinker
9.949400E-01
Non Drinker-vs-Occasional Drinker
7.328200E-02
Non Drinker-vs-Social Drinker
5.011800E-01
Daily Drinker-vs-Weekly Drinker
3.006000E-01
Daily Drinker-vs-Occasional Drinker
1.211540E-02
Daily Drinker-vs-Social Drinker
6.519900E-02
Weekly Drinker-vs-Occasional Drinker
1.212180E-01
Weekly Drinker-vs-Social Drinker
5.550600E-01
Occasional Drinker-vs-Social Drinker
1.989800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.001240E-01
Normal-vs-Grade 2
4.414600E-04
Normal-vs-Grade 3
2.304600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.032000E-01
Grade 1-vs-Grade 3
4.524000E-01
Grade 1-vs-Grade 4
1.001240E-01
Grade 2-vs-Grade 3
3.569400E-01
Grade 2-vs-Grade 4
4.414600E-04
Grade 3-vs-Grade 4
2.304600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.975200E-01
Normal-vs-NonDiabetic
3.942400E-01
Diabetic-vs-NonDiabetic
4.275600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.437800E-01
Normal-vs-NoPancreatitis
3.947400E-01
Pancreatitis-vs-NoPancreatitis
9.272600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.633800E-01
Normal-vs-N1
4.642000E-01
N0-vs-N1
8.736800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.067000E-01
Normal-vs-TP53-NonMutant
4.843400E-01
TP53-Mutant-vs-TP53-NonMutant
1.020600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
